Sentences with phrase «other acquisition financing»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

the Company's share repurchase plans depend on a variety of factors, including the Company's financial position, earnings, share price, catastrophe losses, maintaining capital levels commensurate with the Company's desired ratings from independent rating agencies, funding of the Company's qualified pension plan, capital requirements of the Company's operating subsidiaries, legal requirements, regulatory constraints, other investment opportunities (including mergers and acquisitions and related financings), market conditions and other factors.

The CFO is also focused on the long - term finances of the company in terms of forecasting as well as how the business might fund, say, an acquisition by borrowing or other means.

In the last quarter before completing the acquisition, Innergex had net earnings of $ 3.5 million or five cents per share, down from $ 8.8 million or eight cents per share last year after an increase in financing costs and other financial impairments.

Adjusted Net Income is defined as net income excluding (i) franchise agreement amortization, which is a non-cash expense arising as a result of acquisition accounting that may hinder the comparability of our operating results to our industry peers, (ii) amortization of deferred financing costs and debt issuance discount, a non-cash component of interest expense, and (gains) losses on early extinguishment of debt, which are non-cash charges that vary by the timing, terms and size of debt financing transactions, (iii)(income) loss from equity method investments, net of cash distributions received from equity method investments, (iv) other operating expenses (income), net, and (v) other specifically identified costs associated with non-recurring projects.

As an attorney, Mr. Miller counseled private equity funds, financial institutions, hedge funds, mezzanine and equity funds, and other institutional investors on matters involving mergers and acquisitions, structured and project financings, acquisition financings, recapitalizations, and restructuring and reorganization.

A Dominion Lending Centres leasing professional can help you in discovering multiple ways to structure lease financing for new equipment, a sale - lease back to extract capital from existing assets, or solve other equipment acquisition opportunities.

Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.

By the same token, he says, private equity firms face stiff competition from strategic buyers and a growing number of other financing options, including pension funds, family offices, sovereign wealth funds and special purpose acquisition corporations (SPACs).

GrowthCap is a trade name for GrowthCap, LLC and its subsidiaries and other affiliates which include: GrowthCap Partners, LLC, a Delaware limited liability company, registered broker - dealer and FINRA and SIPC member firm, which provides independent financial advice on private placements, mergers, acquisitions, financial restructurings and similar corporate finance matters, and financial advisory.

Known for her quick and direct approach, Jessie is skilled in financing business acquisitions, partnership buyouts, refinancing, and various other sophisticated business transactions.

Using Private Money — If you have friends, relatives, neighbors, or others who are looking for a better interest rate than the 1 % or so they get from a bank CD or saving's account, they may be interested in lending that money to you to finance your acquisition.

A few other stories relate a crucial 10 seconds in the Teck - Hughes acquisition, the accidental foray into Saskatchewan oil, the Toronto establishment snubbing Afton because of its VSE listing, an underhanded ultimatum from the British Columbia government, getting out of the oyster business and winning an unheard - of 130 % financing for Hemlo.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

As an intern, you will have the opportunity to work on a wide variety of matters such as: appropriations, fiscal law and financial management; acquisitions, financial assistance and public private partnerships; innovative financing; real property and asset management; information technology investment and capital planning; employee ethical conduct, conflicts of interest and political activities; equal employment opportunity and other civil rights matters; Federal personnel and employment; and alternative dispute resolution.

* Estimated payments are for informational purposes only and don't account for acquisition fees, destination charges, tax, title, and other fees and incentives or represent a financing offer or guarantee of credit from the seller.

In the Fund's view, few U.S. corporations are going to go for as long as five years without being involved in resource conversion activities - mergers and acquisitions; changes of control; management buyouts; massive share repurchases; major financings, refinancings or reorganizations; sales of assets in bulk; spin - offs; investing in new ventures in other industries; and corporate liquidations.

Such options include, without limitation, financing transactions, acquisitions, strategic partnerships, corporate restructuring and other activities.

With the board proactively seeking a new strategic direction, which might include «financing transactions, acquisitions, strategic partnerships, corporate restructuring and other activities,» we think there's a good chance that IKAN can realise at least its liquidating value.

These risks include, among others, general economic conditions, local real estate conditions, tenant financial health, the availability of capital to finance planned growth, continued volatility and uncertainty in the credit markets and broader financial markets, property acquisitions and the timing of these acquisitions, charges for property impairments, and the outcome of legal proceedings to which the company is a party, as described in the company's filings with the Securities and Exchange Commission.

Loan investments are often issued in connection with highly leveraged transactions, including leveraged buyout loans, leveraged recapitalization loans, and other types of acquisition financing.

mREITs typically use less borrowing and more equity capital to finance their acquisitions of mortgages and MBS than do other large mortgage investors.

Using Private Money — If you have friends, relatives, neighbors, or others who are looking for a better interest rate than the 1 % or so they get from a bank CD or saving's account, they may be interested in lending that money to you to finance your acquisition.

A Dominion Lending Centres leasing professional can help you in discovering multiple ways to structure lease financing for new equipment, a sale - lease back to extract capital from existing assets, or solve other equipment acquisition opportunities.

Through mergers and acquisitions, capital markets financing, strategic alliances, joint ventures, litigation and other business - related guidance, the firm helps clients in a broad range of industries turn legal challenges into business opportunities.

The company is seeking to pioneer new financing models in rapidly urbanizing areas in Latin America and other developing countries that create sustainable housing at the lowest cost of acquisition and total ownership, through resilient and energy - efficient design and materials use

These include representing AT&T in the complex real estate aspects of the telephone divestiture in 11 western states, representing developers of major high - rise office projects, shopping centers, and other similar developments in an urban context from the initial acquisition, through the entitlement process, financing, construction, leasing and sale.

Peter's private placement practice involves the representation of both issuers and institutional investors in connection with a wide variety of structures and securities, including secured and unsecured senior debt securities, subordinated debt, convertible debt, preferred stock, warrants, trust - preferred securities, merger and acquisition financing, ESOP financings, credit tenant loans, leveraged leases and other structured financings, together with related workout and other restructuring transactions.

Among other transactional areas, Cleary provides experience in mergers, acquisitions and joint ventures; capital markets, derivatives, structured finance, leveraged and acquisition finance; private equity transactions, private fund formation, privatisations, project finance and more.

Mr. Aguilar brings to Shutts more than 20 years of experience representing real estate developers, home builders, financial institutions, private equity funds, and other investors in sophisticated commercial transactions throughout the United States and in Latin America, with an emphasis on acquisitions and dispositions, joint ventures and financings.

He advises lenders and borrowers in connection with a wide range of financing transactions, including investment - grade and leveraged acquisition financings, asset - based credit facilities, cross-border financings, debt restructurings, and other secured and unsecured financings.

Bernie has extensive experience in developing shopping centers and other commercial developments, from acquisition through permitting, environmental issues, financing, and design and construction.

He advises private and public companies on legal issues ranging from entity formation, operations, employee matters, and contract preparation and negotiation to corporate finance and business combination transactions, including securities offerings, debt and equity financing transactions, mergers, stock / asset acquisitions, and other corporate partnering transactions.

As a lawyer, over the last 20 years Vladislav has devoted his practice to advising business clients on corporate and commercial law, real estate, mergers and acquisitions, project financing and public - private partnership, as well as other aspects of business in Russia.

Ferchiou & associés assists domestic and international lenders with acquisition finance and asset finance transactions, including syndicated loans, and capital markets transactions, among other areas.

We also partner with private equity funds to help them successfully execute acquisitions, financings and exit transactions (through M&A and capital market transactions), and we provide transactional and other advice to private equity - owned portfolio companies.

His real estate practice includes the representation of public owners, lenders, borrowers, developers and other corporations in connection with public / private development transactions; zoning and project entitlement; public and private finance; wind, solar and other renewable energy transactions; new market and historical tax credit transactions; build - to - suit and sale leaseback transactions; acquisitions and sales; development; leasing; and other general corporate real estate matters.

Among the transactional services offered by the firm are assistance with mergers & acquisitions; financing vessels and other maritime assets; structuring joint ventures; and other types of complex international agreements and domestic contracts.

Projects: Leading expertise in all aspects of project financings in the energy and infrastructure sectors: oil and gas, petrochemical, power, renewable energy, telecoms, mining, waste and water, PPP / PFI project financing, together with all other aspects of energy and infrastructure - related acquisitions, investment vehicles, hybrid and structured financing and refinancing.

«During his legal career, Sarhan represented clients in diverse transactions including private equity and venture capital financings, mergers and acquisitions, and numerous other transactions involving significant intellectual property assets, including the sale of a well - known US publishing business with considerable copyright assets to a major European publisher and the negotiation of a foreign joint venture for a popular online portal.»

Their experience in particular in helping Chinese companies make energy investments around the world is a perfect fit with Jones Day's global capabilities in energy, mergers and acquisitions, projects and infrastructure, finance, tax, and many other practice areas,» said Jeff Schlegel, head of Jones Day's Energy Practice.

As a member of the firm's finance and renewable energy practices, Fogel will have a wide - ranging practice focused on energy project development, construction, mergers and acquisitions, corporate governance, and other matters, with a special emphasis on solar energy projects.

Our tax lawyers work closely with the firm's business and finance attorneys, identifying and handling the tax consequences of transactions such as taxable mergers and acquisitions, tax - free reorganizations, or the purchases and sales of stock, other equity interests and assets.

We advised lenders on the US$ 33.75 billion bank and bridge acquisition financing for the Teva Pharmaceuticals US$ 40.5 billion acquisition of Allergan / Actavis Generics, the most significant acquisition ever by an Israeli company; GSO Capital, the credit rating arm of the Blackstone Group, in its new $ 1 billion in dedicated acquisition financing to financing Amaya Gambling Group's $ 4.9 billion acquisition of Israeli - owned internet poker giant Rational Group, creating the world's most significant publically traded i - gaming company; recommended lenders, arrangers or debtors in financings for a broad selection of other Israeli companies including the Tshuva Group, Park Plaza Resort Group, Alrov Group (acquisition financings for Café Royal Resort London and Lutetia Resort Paris), Avgol Fibers, Netafim and Eurocom.

Chris provides business and corporate advice, including advice related to sales and acquisitions, commercial leasing, contracts, real estate conveyance and financing; broad commercial litigation representation including contracts and other business disputes, commercial and residential construction defect claims, religious entity law, advice regarding employment disputes and compliance, including ADA, ADEA, Title VII, Colorado Wage Act, FLSA compliance, and administrative proceedings before EEOC and DORA - Colorado Civil Rights Division; representation in administrative proceedings, C.R.C.P. 106 (a)(4) appeals and interlocutory appeals regarding governmental immunity, defense and pursuit of 42 USC § 1983 actions in federal and state court; representation of public pension funds in litigation and administrative matters; and appellate practice before the Colorado Court of Appeals, Colorado Supreme Court, and the 10th Circuit.

VLP also represents its later - stage private clients in venture financings as well as other private equity financings and prepares companies for its IPO or acquisition.

Julie works extensively with start - ups, technology companies and investors on venture capital and other private financings, merger and acquisition transactions and commercial agreements.

Our debt finance group is supported by members of other subgroups within the Business Department, including mergers and acquisitions (for all sizes of transactions, for public and private clients, and on both the buyer and seller sides), investment management (for clients with investment management divisions and matters), small business investment companies (for clients looking to form SBICs, obtain SBIC funding, or conduct portfolio financing transactions), securities (for public clients, particularly with respect to public and Rule 144A debt offerings), tax (including for cross-border transactions), ERISA / employee benefits and international (for clients with international operations and assets), as well as other practice groups within the Firm, including Cleantech & Renewables, Patent, Trademark, Copyright & Unfair Competition practices and the Labor and Employment practice.

Partner Expert in bank lending and other finance options; acquisition, growth and property finance Gatwick

Our corporate practice advises banks and other providers of finance on the financing of major corporate transactions including mergers, acquisitions and joint ventures, both domestic and cross-border.